» Articles » PMID: 29417867

Bioinformatic Analyses of MicroRNA-targeted Genes and Microarray-identified Genes Correlated with Barrett's Esophagus

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2018 Feb 9
PMID 29417867
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Barrett's esophagus (BE) is defined as a metaplasia condition in the distal esophagus, in which the native squamous epithelium lining is replaced by a columnar epithelium with or without intestinal metaplasia. It is commonly accepted that BE is a precancerous lesion for esophageal adenocarcinoma. The aim of this study was to investigate the aberrant microRNAs (miRNAs) and differentially expressed genes (DEGs) associated with BE based on online microarray datasets. One miRNA and five gene expression profiling datasets were retrieved from the Gene Expression Omnibus Database. Aberrant microRNAs and DEGs were obtained using R/Bioconductor statistical analysis language and software. 23 dysregulated miRNAs and 632 DEGs demonstrating consistent expression tendencies in the five gene microarrays were identified in BE. Moreover, 1962 target genes of aberrant miRNAs were predicted using three bioinformatic tools, namely TargetScan, RNA22-HSA and miRDB. Ultimately, 93 target DEGs were obtained, after which functional annotation was performed on DAVID Bioinformatics Resources. Among Gene Ontology (GO) biological processes, digestive tract development and epithelial cell differentiation have demonstrated significant associations with BE pathogenesis. In addition, analysis of the KEGG pathways has revealed associations with cancer. To enable further study, one miRNA-target DEGs regulatory network was constructed using Cytoscape. 6 target DEGs demonstrated higher-degree distributions in the network, and ROC analysis indicated that FNDC3B may be the best potential biomarker for BE diagnosis. The data presented herein may provide new perspectives for exploring BE pathogenesis and may offer hits with regard to potential biomarkers in BE diagnosis, prediction and therapeutic evaluation.

Citing Articles

Prediction and analysis of genetic effect in idiopathic pulmonary fibrosis and gastroesophageal reflux disease.

Chen P, Xie L, Ma L, Zhao X, Chen Y, Ge Z IET Syst Biol. 2023; 17(6):352-365.

PMID: 37907428 PMC: 10725712. DOI: 10.1049/syb2.12081.


Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer.

Martin J, Castellano J, Marrades R, Canals J, Vinolas N, Diaz T Transl Lung Cancer Res. 2021; 10(4):1804-1818.

PMID: 34012794 PMC: 8107756. DOI: 10.21037/tlcr-20-920.


Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.

Craig M, Rajakaruna S, Paliy O, Sajjad M, Madhavan S, Reddy N Clin Transl Gastroenterol. 2020; 11(1):e00125.

PMID: 31934893 PMC: 7056055. DOI: 10.14309/ctg.0000000000000125.


Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.

Zhang H, Zou J, Yin Y, Zhang B, Hu Y, Wang J PeerJ. 2019; 7:e8096.

PMID: 31788359 PMC: 6883955. DOI: 10.7717/peerj.8096.


HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.

Jiang L, Wang R, Fang L, Ge X, Chen L, Zhou M Theranostics. 2019; 9(9):2460-2474.

PMID: 31131047 PMC: 6525996. DOI: 10.7150/thno.31097.


References
1.
Luzna P, Gregar J, Uberall I, Radova L, Prochazka V, Ehrmann Jr J . Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol. 2011; 6:114. PMC: 3268741. DOI: 10.1186/1746-1596-6-114. View

2.
Brown C, Ujiki M . Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence. World J Gastrointest Endosc. 2015; 7(5):438-45. PMC: 4436913. DOI: 10.4253/wjge.v7.i5.438. View

3.
Shaheen N, Falk G, Iyer P, Gerson L . ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2015; 111(1):30-50. PMC: 10245082. DOI: 10.1038/ajg.2015.322. View

4.
Chen H, Zhang Z, Lu Y, Song K, Liu X, Xia F . Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells. Cancer Sci. 2017; 108(9):1811-1819. PMC: 5581518. DOI: 10.1111/cas.13315. View

5.
Poehlmann A, Kuester D, Malfertheiner P, Guenther T, Roessner A . Inflammation and Barrett's carcinogenesis. Pathol Res Pract. 2012; 208(5):269-80. DOI: 10.1016/j.prp.2012.03.007. View